Zibo Liu specializes in competition law and foreign investment related regulatory advice, advising on merger control, antitrust investigation, mock dawn raids and antitrust compliance, both in China and overseas. Zibo works with a broad range of clients, such as industrial enterprises, financial investors, digital platforms, State-owned Enterprises, with sector experience in energy, media, telecoms, healthcare & pharma, auto, aerospace, tech, real estate, chemical, agriculture, finance, insurance, consumer goods, etc.
- Advised Sinochem on its strategic merger with ChemChina, which involved merger filings and relevant consultation in more than 20 jurisdictions across five continents
- Advised GE on its sale of its BioPharma business to Danaher (deal value: USD 21 billion) – China merger filing, cleared with remedies
- Advised a leading international healthcare & pharma company on antitrust investigation by Chinese antitrust authorities
- Advised CVC on global merger filings in relation to its acquisition of Shiseido’s partial personal care business
View all news and client work featuring Zibo Liu
Career and
qualifications
-
China University of Political Science and Law (LLB) 2012
Obtained the PRC legal professional qualification certificate (non-practising) 2012
Cambridge University (LLM) 2013
Joined Clifford Chance 2013
King’s College London (Post-Graduate Diploma EU Competition Law) 2019
Clifford Chance
